ADC THERAPEUTICS SA has a total of 245 patent applications. It increased the IP activity by 28.0%. Its first patent ever was published in 2007. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CURIRX INC, WNTRX PHARMACEUTICALS INC and ONCOQUEST INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 78 | |
#2 | EPO (European Patent Office) | 32 | |
#3 | WIPO (World Intellectual Property Organization) | 20 | |
#4 | Australia | 17 | |
#5 | United States | 16 | |
#6 | Republic of Korea | 15 | |
#7 | Canada | 12 | |
#8 | Brazil | 11 | |
#9 | China | 7 | |
#10 | Hungary | 7 | |
#11 | Serbia | 7 | |
#12 | Mexico | 6 | |
#13 | Israel | 5 | |
#14 | Japan | 4 | |
#15 | New Zealand | 4 | |
#16 | Singapore | 3 | |
#17 | EAPO (Eurasian Patent Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Van Berkel Patricius Hendrikus Cornelis | 82 |
#2 | Howard Philip Wilson | 45 |
#3 | Hartley John | 37 |
#4 | Wuerthner Jens | 35 |
#5 | Zammarchi Francesca | 34 |
#6 | Feingold Jay Marshall | 32 |
#7 | Filion Mario | 25 |
#8 | Tremblay Gilles Bernard | 21 |
#9 | Moraitis Anna N | 15 |
#10 | Van Berkel Patricius Henrikus Cornelis | 10 |
Publication | Filing date | Title |
---|---|---|
GB202102396D0 | Molecular adjuvant | |
GB202015916D0 | Combination therapy | |
GB202014255D0 | Compounds | |
GB202012161D0 | Combination therapy | |
GB202011993D0 | ANTI-IL 13Ra2 antibodies | |
GB202010751D0 | Anti-mesothelin antibodies | |
WO2020249527A1 | Combination therapy comprising an anti-cd25 antibody drug conjugate and a further agent | |
WO2020249528A1 | Combination therapy comprising an anti-cd19 antibody drug conjugate and a pi3k inhibitor or a secondary agent | |
GB202007015D0 | Pyrrolobenzodiazepine phototherapy | |
WO2020127573A1 | Pyrrolobenzodiazepine resistance | |
GB201917254D0 | Combination therapy | |
WO2020109251A1 | Dosage regime | |
GB201912850D0 | Compounds | |
CA3107085A1 | Combination therapy | |
GB201908232D0 | Combination Therapy | |
GB201908231D0 | Combination therapy | |
GB201908225D0 | Combination therapy | |
GB201908227D0 | Combination therapy | |
GB201908234D0 | Combination therapy | |
GB201908233D0 | Combination therapy |